Changyu Ren

Statistics

Publications

Citations

136

H-Index

Active since

2020

Affiliations

Chengdu Fifth People's Hospital(Current)

Changyu Ren is an author at Chengdu Fifth People's Hospital specializing in phase i clinical trials, small molecule tyrosine kinase inhibitors, and apoptosis targeting.

Publications per year

2020–2024

Publications

Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation

Yuanxin Guo, Xiaohong Tracey Gan, Houfeng Zhou et al. · Life Sciences · 2020 · 87 citations

Life Sciences, Neuroscience, Pharmacology +10

Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles

Li Chen, Wuyu Mao, Changyu Ren et al. · Journal of Medicinal Chemistry · 2024 · 27 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Montelukast prevents mice against carbon tetrachloride- and methionine-choline deficient diet-induced liver fibrosis: Reducing hepatic stellate cell activation and inflammation

Shiyun Pu, Jingyi Zhang, Changyu Ren et al. · Life Sciences · 2023 · 11 citations

Medicine, Cell Biology, Pharmacology +17

Delving into Commit-Issue Correlation to Enhance Commit Message Generation Models

Liran Wang, Xunzhu Tang, Yichen He et al. · 2023 · 11 citations · Full text

Computing, Computer Science, Information Retrieval +12

1–4 of 4